Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain
复制标题
DOI：
10.1097/00002508-200409000-00005
复制
发表时间：
2004-09-01
影响因子：
2.9
通讯作者：
Cleeland, CS
中科院分区：
文献类型：
--
作者：
Keller, S;Bann, CM;Cleeland, CS
目的：简明疼痛量表（BPI）是一个简短的，自我管理的问卷调查，开发用于癌症患者。虽然大多数关于BPI的实证研究都是针对这种病因的疼痛，但在已发表的非癌症疼痛患者的研究中，问卷调查越来越明显。目前的研究解决了需要正式评估的信度和效度的BPI用于非癌症patients.Methods：约250例关节炎或腰痛（LBP）自我管理的一些通用和条件特定的健康状况的措施（包括BPI）在2个时间点在他们的初级保健提供者的诊所中：初始诊所访视和治疗后的首次访视。从非癌症疼痛患者中收集的BPI数据的可靠性与文献中报告的癌症患者数据相当，足以进行组水平分析（系数α大于0.70）。BPI的因子结构在该样本中得到了复制，BPI与疼痛的通用测量的关系很强。BPI表现出与一般和特定条件的健康指标相似的关系，就像通用保罗量表（SF-36身体疼痛）一样。最后，BPI之间的歧视水平的条件的严重程度和敏感的变化，随着时间的推移，在关节炎和LBP patients.Discussion：结果支持的有效性的BPI作为一种措施的疼痛，在没有癌症的患者，特别是，作为一种措施的疼痛关节炎和LBP患者。
Objectives: The Brief Pain Inventory (BPI) is a short, self-administered questionnaire that was developed for use in cancer patients. While most empirical research with the BPI has been in pain of that etiology, the questionnaire is increasingly evident in published studies of patients with non-cancer pain. The current research addresses the need for formal evaluation of the reliability and validity of the BPI for use in non-cancer pain patients.Methods: Approximately 250 patients with arthritis or low back pain (LBP) self-administered a number of generic and condition-specific health status measures (including the BPI) in the clinic of their primary care provider at 2 time points: the initial clinic visit and the first visit following treatment.Results: The reliability of BPI data collected from non-cancer pain patients was comparable to that reported in the literature for cancer patients and Sufficient for group-level analyses (coefficient alphas were greater than 0.70). The factor structure of the BPI was replicated in this sample and the relationship of the BPI to generic measures of pain was strong. The BPI exhibited similar relationships to general and condition-specific measures of health as did a generic Paul scale (SF-36 Bodily Pain). Finally, the BPI discriminated among levels of condition severity and was sensitive to change in condition over time in arthritis and LBP patients.Discussion: Results support the validity of the BPI as a measure of pain in patients without cancer and, in particular, as a measure of pain for arthritis and LBP patients.